+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

  • PDF Icon

    Report

  • 86 Pages
  • March 2022
  • Region: Global
  • Transparency Market Research
  • ID: 5591631
This report on the global deep brain stimulation devices market for Parkinson’s disease studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global deep brain stimulation devices market for Parkinson’s disease for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global deep brain stimulation devices market for Parkinson’s disease from 2021 to 2028.



The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the deep brain stimulation devices market for Parkinson’s disease.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global deep brain stimulation devices market for Parkinson’s disease.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global deep brain stimulation devices market for Parkinson’s disease. These serve as valuable tools for existing market players as well as for entities interested in participating in the global deep brain stimulation devices market for Parkinson’s disease.

The report delves into the competition landscape of the global deep brain stimulation devices market for Parkinson’s disease. Key players operating in the global deep brain stimulation devices market for Parkinson’s disease have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global deep brain stimulation devices market for Parkinson’s disease profiled in this report.

Key Questions Answered in Deep Brain Stimulation Devices Market for Parkinson’s Disease Report

  • What will be the sales revenue generated by each country of the market across all regions during the forecast period?
  • What are the key trends in the global deep brain stimulation devices market for Parkinson’s disease?
  • What are major drivers, restraints, and opportunities in the global deep brain stimulation devices market for Parkinson’s disease?
  • The market in which region is likely to expand at a high CAGR during the forecast period?
  • Which segment of the global deep brain stimulation devices market for Parkinson’s disease will generate the maximum revenue by 2028? Which product segment will expand at the fastest CAGR during the forecast period?

Deep Brain Stimulation Devices Market for Parkinson’s Disease - Research Objectives and Research Approach

The comprehensive report on the global deep brain stimulation devices market for Parkinson’s disease begins with an overview, followed by the scope and objectives of the study.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global deep brain stimulation devices market for Parkinson’s disease in terms of product type, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global deep brain stimulation devices market for Parkinson’s disease.
Frequently Asked Questions about the Global Deep Brain Stimulation Devices Market

What is the estimated value of the Global Deep Brain Stimulation Devices Market?

The Global Deep Brain Stimulation Devices Market was estimated to be valued at $0.85 Billion in 2021.

What is the growth rate of the Global Deep Brain Stimulation Devices Market?

The growth rate of the Global Deep Brain Stimulation Devices Market is 5.1%, with an estimated value of $1.2 Billion by 2028.

What is the forecasted size of the Global Deep Brain Stimulation Devices Market?

The Global Deep Brain Stimulation Devices Market is estimated to be worth $1.2 Billion by 2028.

Who are the key companies in the Global Deep Brain Stimulation Devices Market?

Key companies in the Global Deep Brain Stimulation Devices Market include Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Inc. and Medtronic.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, 2017-2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Product Type
6.1. Key Findings
6.2. Market Value Forecast, by Product Type
6.2.1. Single-Channel Deep Brain Stimulator
6.2.2. Dual-Channel Deep Brain Stimulator
6.3. Market Attractiveness Analysis, by Product Type
7. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by End-user
7.1. Key Findings
7.2. Market Value Forecast, by End-user
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Neurological Clinics
7.2.4. Others
7.3. Market Attractiveness Analysis, by End-user
8. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2028
9.2.1. Single-Channel Deep Brain Stimulator
9.2.2. Dual-Channel Deep Brain Stimulator
9.3. Market Attractiveness Analysis, by Product Type
9.4. Market Value Forecast, by End-user, 2017-2028
9.5. Market Value Forecast, by End-user
9.5.1. Hospitals
9.5.2. Ambulatory Surgical Centers
9.5.3. Neurological Clinics
9.5.4. Others
9.6. Market Attractiveness Analysis, by End-user
9.7. Market Value Forecast, by Country/Sub-region, 2017-2028
9.7.1. U.S.
9.7.2. Canada
9.8. Market Attractiveness Analysis
9.8.1. By Product Type
9.8.2. By End-user
9.8.3. By Country/Sub-region
10. Europe Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2028
10.2.1. Single-Channel Deep Brain Stimulator
10.2.2. Dual-Channel Deep Brain Stimulator
10.3. Market Attractiveness Analysis, by Product Type
10.4. Market Value Forecast, by End-user, 2017-2028
10.5. Market Value Forecast, by End-user
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Neurological Clinics
10.5.4. Others
10.6. Market Attractiveness Analysis, by End-user
10.7. Market Value Forecast, by Country/Sub-region, 2017-2028
10.7.1. Germany
10.7.2. U.K.
10.7.3. France
10.7.4. Spain
10.7.5. Italy
10.7.6. Rest of Europe
10.8. Market Attractiveness Analysis
10.8.1. By Product Type
10.8.2. By End-user
10.8.3. By Country/Sub-region
11. Asia Pacific Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2028
11.2.1. Single-Channel Deep Brain Stimulator
11.2.2. Dual-Channel Deep Brain Stimulator
11.3. Market Attractiveness Analysis, by Product Type
11.4. Market Value Forecast, by End-user, 2017-2028
11.5. Market Value Forecast, by End-user
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Neurological Clinics
11.5.4. Others
11.6. Market Attractiveness Analysis, by End-user
11.7. Market Value Forecast, by Country/Sub-region, 2017-2028
11.7.1. China
11.7.2. Japan
11.7.3. India
11.7.4. Australia & New Zealand
11.7.5. Rest of Asia Pacific
11.8. Market Attractiveness Analysis
11.8.1. By Product
11.8.2. By Application
11.8.3. By Country/Sub-region
12. Latin America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2028
12.2.1. Single-Channel Deep Brain Stimulator
12.2.2. Dual-Channel Deep Brain Stimulator
12.3. Market Attractiveness Analysis, by Product Type
12.4. Market Value Forecast, by End-user, 2017-2028
12.5. Market Value Forecast, by End-user
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Neurological Clinics
12.5.4. Others
12.6. Market Attractiveness Analysis, by End-user
12.7. Market Value Forecast, by Country/Sub-region, 2017-2028
12.7.1. Brazil
12.7.2. Mexico
12.7.3. Rest of Latin America
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Application
12.8.3. By Country/Sub-region
13. Middle East & Africa Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2028
13.2.1. Single-Channel Deep Brain Stimulator
13.2.2. Dual-Channel Deep Brain Stimulator
13.3. Market Attractiveness Analysis, by Product Type
13.4. Market Value Forecast, by End-user, 2017-2028
13.5. Market Value Forecast, by End-user
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Neurological Clinics
13.5.4. Others
13.6. Market Attractiveness Analysis, by End-user
13.7. Market Value Forecast, by Country/Sub-region, 2017-2028
13.7.1. GCC Countries
13.7.2. South Africa
13.7.3. Rest of Middle East & Africa
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Application
13.8.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Aleva Neurotherapeutics SA
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Boston Scientific Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medtronic, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Medtronic
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Medtronic